Menopause-specific questionnaire assessment in US population-based study shows negative impact on health-related quality of life

Maturitas

Volumn 62, Issue 2, 2009, Pages 153-159

  Williams, Rachel E ^a   Levine, Kristen B ^b   Kalilani, Linda ^b   Lewis, Jacqueline ^c   Clark, Richard V ^a  

^a GLAXOSMITHKLINE   (United States)

^b The University of North Carolina at Chapel Hill   (United States)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Hot flashes; Menopause; MENQOL; Quality of life; Vasomotor symptoms

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; EDUCATIONAL STATUS; FEMALE; HOT FLUSH; HUMAN; LEISURE; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MENOPAUSE; MOOD; POSTMENOPAUSE; QUALITY OF LIFE; QUESTIONNAIRE; SEXUAL BEHAVIOR; SLEEP; SOCIAL BEHAVIOR; VASOMOTOR DISORDER;

ADULT; AGED; BODY MASS INDEX; EXERCISE; FEMALE; HEALTH SURVEYS; HOT FLASHES; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PSYCHOLOGY; QUALITY OF LIFE; QUESTIONNAIRES; SMOKING; SOCIOECONOMIC FACTORS; UNITED STATES; VASOMOTOR SYSTEM;

EID: 61349087285     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2008.12.006     Document Type: Article

References (35)

1. Greendale G.A., Lee N.P., and Arriola E.R. The menopause. Lancet 353 (1999) 571-580
2. World Health Organization (WHO) Scientific Group. Research on the Menopause in the 1990s. Geneva, Switzerland; World Health Organization; 1996. WHO Technical Report Series, No. 866.
3. Gold E.B., Sternfeld B., Kelsey J.L., et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol 152 (2000) 463-473
4. Anderson E., Hamburger S., Liu J.H., and Rebar R.W. Characteristics of menopausal women seeking assistance. Am J Obstet Gynecol 156 (1987) 428-433
5. Hilditch J.R., Lewis J., Ross A.H., et al. A comparison of the effects of oral conjugated equine estrogen and transdermal estradiol-17 beta combined with an oral progestin on quality of life in postmenopausal women. Maturitas 24 (1996) 177-184
6. Gelfand M.M., Moreau M., Ayotte N.J., Hilditch J.R., Wong B.A., and Lau C.Y. Clinical assessment and quality of life of postmenopausal women treated with a new intermittent progestogen combination hormone replacement therapy: a placebo-controlled study. Menopause 10 (2003) 29-36
7. Davis S.R., Davison S.L., Wilson S., Shepherd J., and Lawton B. Intranasal versus transdermal matrix oestrogen replacement in Australasian women. Maturitas 51 (2005) 163-171
8. Ledesert B., Ringa V., and Breart G. Menopause and perceived health status among the women of the French GAZEL cohort. Maturitas 20 (1994) 113-120
9. Chedraui P., Aquirre W., Hidalgo L., et al. Assessing menopausal symptoms among healthy middle aged women with the Menopause Rating Scale. Maturitas 57 3 (2007) 271-278
10. Monterrosa A., Blumel J., and Chedraui P. Increased menopausal symptoms among Afro-Colombian women as assessed with the Menopause Rating Scale. Maturitas 59 (2008) 182-190
11. Binfa L., Castelo-Branco C., Blumel J., et al. Influence of psycho-social factors on climacteric symptoms. Maturitas 48 (2004) 425-431
12. Blumel J., Castelo-Branco C., Binfa L., et al. Quality of Life after the menopause: a population study. Maturitas 34 (2000) 17-23
13. Hilditch J.R., Lewis J., Peter A., et al. A Menopause-Specific Quality of Life Questionnaire: development and psychometric properties. Maturitas 24 (1996) 161-175
14. Williams R.E., Kalilani L., DiBenedetti D.B., et al. Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States. Climacteric 11 (2008 Feb) 32-43
15. 17. US Current Population Survey (CPS) February 2002. Available at: http://www.bls.census.gov/cps/cpsmain.htm. Retrieved April-May 2005.
16. Williams R.E., Kalilani L., DiBenedetti D.B., Zhou X., Fehnel S.E., and Clark R.V. Healthcare seeking behavior and treatment of menopausal symptoms among peri- and postmenopausal women in the United States. Maturitas 58 4 (2007) 348-358
17. Levine K.B., Williams R.E., and Hartmann K.E. Vulvo-vaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women. Menopause 15 4 (2008) 661-666
18. Lewis J.E., Hilditch J.R., and Wong C.J. Further psychometric property development of the Menopause-Specific Quality of Life Questionnaire and development of a modified version. MENQOL-Intervention questionnaire. Maturitas 50 (2005) 209-221
19. Centers for Disease Control. Body Mass for Adults. http://www.cdc.gov/nccdphp/dnpa/healthyweight/assessing/bmi/adult_BMI/ab out_adult_BMI.htm.
20. Food and Drug Administration (FDA). Guidance for industry. Estrogen and estrogen/progestin drug products to treat vasomotor symptoms and vulvar and vaginal atrophy symptoms-recommendations for clinical evaluation. January 2003. Available at: http://www.fda.gov/OHRMS/DOCKETS/98fr/5054dft.doc. Retrieved March 15, 2005.
21. Olofsson A.S., and Collins A. Psychosocial factors, attitude to menopause and symptoms in Swedish perimenopausal women. Climacteric 3 (2000) 33-42
22. Kuh D.L., Wadsworth M., and Hardy R. Women's health in midlife: the influence of the menopause, social factors and health in earlier life. Br J Obstet Gynaecol 104 (1997) 923-933
23. Avis N.E., Stellato R., Crawford S., et al. Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups. Soc Sci Med 52 (2001) 345-356
24. Gold E.B., Block G., Crawford S., et al. Lifestyle and demographic factors in relation to vasomotor symptoms: baseline results from the Study of Women's Health Across the Nation. Am J Epidemiol 159 (2004) 1189-1199
25. Ford K., Sowers M., Crutchfield M., Wilson A., and Jannausch M. A longitudinal study of the predictors of prevalence and severity of symptoms commonly associated with menopause. Menopause 12 (2005) 308-317
26. Li C., Borgfeldt C., Samsioe G., Lidfeldt J., and Nerbrand C. Background factors influencing somatic and psychological symptoms in middle-age women with different hormonal status. A population-based study of Swedish women. Maturitas 52 (2005) 306-318
27. Freeman E.W., Sammel M.D., Grisso J.A., Battistini M., Garcia-Espagna B., and Hollander L. Hot flashes in the late reproductive years: risk factors for Africa American and Caucasian women. J Womens Health Gend Based Med 10 (2001) 67-76
28. Gallicchio L., Visvanathan K., Miller S., et al. Body mass, estrogen levels, and hot flashes in midlife women. Am J Obstet Gynecol 193 (2005) 1353-1360
29. Centers for Disease Control and Prevention. Table A-1. Prevalence of BMI 25+ by age, sex, and survey. Available at: http://www.cdc.gov/nchs/data/nhanes/overweight.pdf. Retrieved on December 5, 2008.
30. Gold E.B., Colvin A., Avis N., et al. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation. Am J Public Health 96 (2006) 1226-1235
31. Robinson G. Cross-cultural perspectives on menopause. J Nerv Ment Dis 184 (1996) 453-458
32. Oldenhave A., Jaszmann L.J., Haspels A.A., and Everaerd W.T. Impact of climacteric on well-being. A survey based on 5213 women 39 to 60 years old. Am J Obstet Gynecol 168 (1993) 772-780
33. Chedraui P., Hidalgo L., Chavez D., Morocho N., Alvarado M., and Huc A. Menopausal symptoms and associated risk factors among postmenopausal women screened for the metabolic syndrome. Arch Gyencol Obstet 275 3 (2007) 161-168
34. Lu J., Liu J., and Eden J. The experience of menopausal symptoms by Arabic women in Sydney. Climacteric 10 (2007) 72-79
35. Peeyananjarassri K., Cheewadhanaraks S., Hubbard M., et al. Menopausal Symptoms in a hospital-based sample of women in southern Thailand. Climacteric 9 (2006) 23-29